Eyam Vaccines and Immunotherapeutics2024-03-19T19:02:25+00:00

NEXT GEN PLATFORMS FOR VACCINES & NANOMEDICINE

ON DEMAND

Our next generation platforms, the Jennerator and Gemini, are pandemic ready and can be customized to design and deliver vaccines and immunotherapeutics on demand.

Machine Learning

The Jennerator UTILIZES AI and machine learning to design vaccines and therapeutics on demand for any virus or cancer tumor.

Proprietary Algorithms

The AI and proprietary algorithms in the Jennerator mine large datasets and predict the best epitope targets for the most effective therapies.

JENNERATOR

Delivery

Gemini’s superior delivery system presents therapeutic and vaccine payloads.

Stability

Gemini is incredibly stable as a HIGHLY FOLDED structure, withstanding multiple freeze/thaw cycles WHILE REMAINING functional after lypohilization.

GEMINI

Why Eyam?
Our Technology

Eyam Vaccines and Immunotherapeutics is a platform biotech company focused on the design and delivery of therapies that are safe, efficacious and low dose.

Mission

Our mission is to design, develop and bring to market next generation platform technologies for safer and more effective vaccines and therapeutics.

Vision

Our vision is to pave the way for a new era of safer, highly effective, lower dose vaccines and therapeutics.

Founding story

Founded by Dr. Jefferies, a Canadian expert in virology, oncology, and immunology, Eyam aims to revolutionize healthcare. Our multidisciplinary team of scientists and biotechnology leaders is dedicated to next-generation platform technologies, ensuring swift, safe, and effective solutions.

HOW WE ARE ADDRESSING MARKET LIMITATIONS

OUR SOLUTIONS

GROUND-BREAKING ADVANCED BIO-TECHNOLOGY

Tomorrow’s Technology, Today.

  • EYAM harnesses its platform technologies to collaboratively deliver on-demand vaccines and immunotherapeutics, serving both local and global communities.

Stay informed about Eyam’s progress.

Sign up for our newsletter.

Meet Our Leadership Team

Meet Our Board Members

Meet Our Advisory Board

IN THE NEWS TODAY

Eyam Welcomes Wolfgang Koester to Board of Directors

March 18th, 2024|

Over the last several months, it seems like we’ve been on a COVID-19 Rollercoaster. First, the long-awaited vaccines rolled out and a subsequent decline in cases was reported in regions where vaccines were rolled out quickly.

PARTNER WITH US

Follow Eyam On Social Media

To Get latest Updates

 Eyam Vaccines and Immunotherapeutics

205-810 Quayside Drive, New Westminster, BC, V3M 6B9
[email protected]

Phone: +1 (778) 381-1075
Email: [email protected]

Go to Top